Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Adenocarcinoma of Lung 3Squamous Cell Carcinoma of Head and Neck 2Lung Neoplasms 2Esophageal Neoplasms 2Barrett Esophagus 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Skin Neoplasms 1Salivary Gland Neoplasms 1Precancerous Conditions 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Basal Cell 1Adenocarcinoma, Follicular 1Adenocarcinoma Of Esophagus 1

Interventions

aldesleukin 9Interleukin-2 9Nivolumab 7fludarabine phosphate 6Dacarbazine 6Cyclophosphamide 6fludarabine 5Temozolomide 4Ipilimumab 4Fluorouracil 4montanide ISA 51 3Surveys and Questionnaires 3Semaxinib 3Radiotherapy 3Radiation 3Mohs Surgery 3Educational Status 3Cisplatin 3Allovectin-7 3zanolimumab 2talabostat 2sonidegib 2poly ICLC 2binimetinib 2Whole-Body Irradiation 2Vinblastine 2Vemurafenib 2Tacrolimus 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Skin Neoplasms × 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a × Clear all
NCT00017485 2011-03-07

Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer

Roswell Park Cancer Institute

Phase 1 Completed
6 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡